Dual positivity of hepatitis B surface antigen and anti-hepatitis C virus antibody and associated factors among apparently healthy patients of Ekiti State, Nigeria

Viral Immunol. 2012 Dec;25(6):448-55. doi: 10.1089/vim.2012.0042. Epub 2012 Nov 21.

Abstract

There are few studies on health-facility based prevalence rates for dual hepatitis B virus-hepatitis C virus (HBV-HCV) infection on a state-wide scale in Nigeria. In this study we determined the state-wide prevalence rate of dual positivity of hepatitis B surface antigen and anti-HCV antibody among hospital patients of Ekiti State, Nigeria, and identified associated factors. Consenting apparently-healthy patients visiting health centers in all local government area (LGA) headquarters of Ekiti State were consecutively selected to a total of 2000 individuals. Patient demographic data pertinent to HBV and HCV transmission were obtained using a structured questionnaire. Subsequently, serum samples prepared from the aseptically collected blood was tested for the presence of both HBsAg and anti-HCV antibody using DiaSpot test strips. The results were analyzed using binary logistic regression. Dual positivity of 7.40% was recorded among the study participants, with 9.80% and 12.80%, respectively, testing positive for HBsAg and anti-HCV antibody. The study patients were, however, most likely to be anti-HCV antibody positive. Nine of the 10 factors studied were independently associated with dual positivity. Five of these, in descending order of odds ratio, were: illiteracy (15.76, p=0.001); having ≥4 sexual partners (9.46, p=0.001); age range of 35-44 y (8.46,p=0.001); farming (7.33, p=0.001); and "not at all" to use of condoms during sexual intercourse (4.39, p=0.001). The dual positivity rate was relatively high, with unprotected sexual intercourse as the most probable mode of acquisition of HBV and HCV by the seropositive study participants.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Asymptomatic Diseases / epidemiology
  • Coinfection / epidemiology*
  • Cross-Sectional Studies
  • Female
  • Hepacivirus / immunology*
  • Hepatitis B / diagnosis
  • Hepatitis B / epidemiology*
  • Hepatitis B Surface Antigens / blood*
  • Hepatitis B virus / immunology*
  • Hepatitis C / diagnosis
  • Hepatitis C / epidemiology*
  • Hepatitis C Antibodies / blood*
  • Humans
  • Male
  • Middle Aged
  • Nigeria / epidemiology
  • Risk Factors
  • Seroepidemiologic Studies
  • Young Adult

Substances

  • Hepatitis B Surface Antigens
  • Hepatitis C Antibodies